Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 18 , ISSUE 7 ( July, 2014 ) > List of Articles

RESEARCH ARTICLE

Comparison of clonidine and dexmedetomidine for short-term sedation of intensive care unit patients

Aditya Kumar, Amrita Gupta, Yogita Dwivedi, Tapas Kumar Singh, Uma Srivastava, Mita Eunice Sarkar, Archana Agarwal, Vivek Badada

Keywords : Clonidine, dexmedetomidine, intensive care unit sedation

Citation Information : Kumar A, Gupta A, Dwivedi Y, Singh TK, Srivastava U, Sarkar ME, Agarwal A, Badada V. Comparison of clonidine and dexmedetomidine for short-term sedation of intensive care unit patients. Indian J Crit Care Med 2014; 18 (7):431-436.

DOI: 10.4103/0972-5229.136071

License: CC BY-ND 3.0

Published Online: 01-07-2014

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background and Objectives: Patients on mechanical ventilation in intensive care unit (ICU) are often uncomfortable because of anxiety, pain, and endotracheal intubation; therefore, require sedation. Alpha-2 agonists are known to produce sedation. We compared clonidine and dexmedetomidine as sole agents for sedation. Study Design: Prospective, randomized, controlled open-label study. Materials and Methods: A total of 70 patients requiring a minimum of 12 h of mechanical ventilation with concomitant sedation, were randomly allocated into two groups. Group C (n = 35) received intravenous (IV) clonidine (1 μg/kg/h titrated up to 2 μg/kg/h to attain target sedation), and Group D (n = 35) received IV dexmedetomidine for sedation (loading 0.7 μg/kg and maintenance 0.2 μg/kg/h titrated up to 0.7 μg/kg/h to achieve target sedation). A Ramsay Sedation Score of 3-4 was considered as target sedation. Additional sedation with diazepam was given when required to achieve target sedation. The quality of sedation, hemodynamic changes and adverse effects were noted and compared between the two groups. Results: Target sedation was achieved in 86% observations in Group D and 62% in Group C (P = 0.04). Additional sedation was needed by more patients in Group C compared with Group D (14 and 8 in Groups C and D, respectively, P = 0.034), mainly due to concomitant hypotension on increasing the dose of clonidine. Hypotension was the most common side-effect in Group C, occurring in 11/35 patients of Group C and 3/35 patients of Group D (P = 0.02). Rebound hypertension was seen in four patients receiving clonidine, but none in receiving dexmedetomidine. Conclusion: Both clonidine and dexmedetomidine produced effective sedation; however, the hemodynamic stability provided by dexmedetomidine gives it an edge over clonidine for short-term sedation of ICU patients.


PDF Share
  1. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, et al. Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001;286:2703-10.
  2. Devlin JW. The pharmacology of oversedation in mechanically ventilated adults. Curr Opin Crit Care 2008;14:403-7.
  3. Rowe K, Fletcher S. Sedation in the intensive care unit. Contin Educ Anesth Crit Care 2008;8:50-5.
  4. Gowing L, Farrell M, Ali R, White JM. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev 2004 ;4:CD002024.
  5. Bernard JM, Kick O, Bonnet F. Comparison of intravenous and epidural clonidine for postoperative patient-controlled analgesia. Anesth Analg 1995;81:706-12.
  6. Hall JE, Uhrich TD, Ebert TJ. Sedative, analgesic and cognitive effects of clonidine infusions in humans. Br J Anaesth 2001;86:5-11.
  7. Pichot C, Ghignone M, Quintin L. Dexmedetomidine and clonidine: From second- to first-line sedative agents in the critical care setting? J Intensive Care Med 2012;27:219-37.
  8. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999;54:1136-42.
  9. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: Patient and clinician perceptions. Br J Anaesth 2001;87:684-90.
  10. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000;59:263-8.
  11. Riker RR, Ramsay MA, Prielipp RC, Jorden V. Long-term dexmedetomidine infusion for ICU sedation: A pilot study [Abstract]. Anesthesiology 2001;95:A383.
  12. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009;301:489-99.
  13. Gillison M, Fairbaim J, McDonald K, Zvonar R, Cardinal P. Clonidine use in the intensive care unit of a tertiary care hospital: Retrospective analysis. Can J Hosp Pharm 2004;57:83-9.
  14. Martin E, Ramsay G, Mantz J, Sum-Ping ST. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003;18:29-41.
  15. Jamadarkhana S, Gopal S. Clonidine in adults as a sedative agent in the intensive care unit. J Anaesthesiol Clin Pharmacol 2010;26:439-45.
  16. Venn RM, Ball J, Steele A, Newman PJ, Grounds RM. Dexmedetomidine for sedation in the ICU. Crit Care 2000;4 Suppl 1:P192.
  17. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 2007;298:2644-53.
  18. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: Sedative and cardiovascular effects. Intensive Care Med 2004;30:2188-96.
  19. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients; a meta-analysis. Intensive Care Med. 2010 Jun;36:926-39
  20. Sudheesh K, Harsoor S. Dexmedetomidine in anaesthesia practice: A wonder drug? Indian J Anaesth 2011;55:323-4.
  21. Venn M, Newman J, Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 2003;29:201-7.
  22. Takrouri MS, Seraj MA, Channa AB, el-Dawlatly AA, Thallage A, Riad W, et al. Dexmedetomidine in intensive care unit: A study of hemodynamic changes. Middle East J Anesthesiol 2002;16:587-95.
  23. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992;77:1134-42.
  24. Böhrer H, Bach A, Layer M, Werning P. Clonidine as a sedative adjunct in intensive care. Intensive Care Med 1990;16:265-6.
  25. Consales G, Chelazzi C, Rinaldi S, De Gaudio AR. Bispectral Index compared to Ramsay score for sedation monitoring in intensive care units. Minerva Anestesiol 2006;72:329-36.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.